Top news of the week: 16.06.2021.
Startups
Investor interest in Alzheimer’s ‘changed on the dime’ following FDA’s decision on Biogen’s aducanumab
The FDA's conditional approval of Biogen's Aduhelm has already spurred investor interest in Alzheimer's treatments currently in the clinic.
Life sciences is poised to be Boston’s dominant industry. Has the area become the Silicon Valley of biotech?
Since December, you can find six major indications that Boston is the undisputed center of the life sciences industry, a place where ideas and products that change — and save — people’s ...
Novavax says its coronavirus vaccine was 90% effective in a large trial, moving the shot a step closer to widespread use
Novavax fell behind rivals like Pfizer and Moderna, and the biotech's launch timeline remains hazy.
Maryland Governor Larry Hogan Named BIO’s Governor of the Year
Today, the Biotechnology Innovation Organization (BIO) presented Maryland Governor Larry Hogan with its 2021 Governor of the Year Award. Governor Hogan received the award virtually at BIO ...
Flagship Pioneering, The Investor Behind Moderna, Raises $3.4 Billion For New Fund
Flagship Pioneering, the investor behind Covid-19 vaccine maker Moderna, said today that it had raised $3.4 billion for a new fund.
Moderna founder raises another $2B to fuel new startups
Flagship Pioneering reopened one of its funds in April, quickly raising fresh cash for new biotech investments.
An Update on Clinical Development and Therapeutic Company Funding and Deals
As the COVID-19 pandemic impacted the entire world, glimmers of hope that shined through the dark past year in large part came from the biotechnology sector. One of the most important ...